RSS   Newsletter   Contact   Advertise with us
Post Online Media
Acquisition   Accord Healthcare bought some assets

Teva completes £603 million sale of UK and Ireland Actavis assets

TevaTeva Pharmaceutical Industries completed the sale of the majority of the assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited, a subsidiary of Intas Pharmaceuticals Ltd.

Article continues below


READ MORE Mylan: Teva's stake buy violates U.S. anti-trust rules



The sale, first announced in October last year, has completed for an agreed value of £603 million following approval from the European Commission.

The divestment of specified Actavis Generics assets and operations in the UK and Ireland was part of an undertaking that Teva made to the European Commission in order to obtain approval to proceed with its acquisition of Actavis Generics last year.

The sale includes a portfolio of generic medicines plus a manufacturing plant in Barnstaple, England. Within the UK and Ireland Teva retains a number of Actavis non-overlapping generic products plus certain specialty medicines and OTC (over-the-counter) products, which have been added to Teva’s existing businesses.


What to read next
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy